Hera - Mi
Hera-MI is a French MedTech startup founded in 2017, based in Nantes, specializing in AI for medical imaging, particularly for cancer diagnosis. Their primary product, Breast-SlimView®, is a patented AI-powered decision support software for 2D and 3D mammography, designed to improve the accuracy and efficiency of breast cancer detection. The company distributes Breast-SlimView® internationally through direct sales and commercial partners. Hera-MI's mission is to enhance healthcare systems with AI, benefiting radiologists, senologists, and patients by supporting medical decision-making and improving diagnostic quality. They emphasize their commitment to innovation and scientific collaboration, having partnered with research institutions like the Laboratoire des Sciences du Numérique de Nantes (LS2N). The company has received several awards and recognitions for its innovative approach.
Hera - Mi
Hera-MI is a French MedTech startup founded in 2017, based in Nantes, specializing in AI for medical imaging, particularly for cancer diagnosis. Their primary product, Breast-SlimView®, is a patented AI-powered decision support software for 2D and 3D mammography, designed to improve the accuracy and efficiency of breast cancer detection. The company distributes Breast-SlimView® internationally through direct sales and commercial partners. Hera-MI's mission is to enhance healthcare systems with AI, benefiting radiologists, senologists, and patients by supporting medical decision-making and improving diagnostic quality. They emphasize their commitment to innovation and scientific collaboration, having partnered with research institutions like the Laboratoire des Sciences du Numérique de Nantes (LS2N). The company has received several awards and recognitions for its innovative approach.
TL;DR
Founded: 2017 (Nantes, France)
Core product: Breast-SlimView® — AI decision-support for 2D mammography and 3D tomosynthesis
Regulatory: CE marked (November 2019)
Team size: ~25 employees
Funding signal: Non-equity assistance (Oct 21, 2020); listed supporters and investors include Ouest Angels, WISEED, Bpifrance
Company Overview
Problem Domain
Breast cancer imaging; clinical decision support for mammography and tomosynthesis
Founded
2017
Industry
MedTech / Medical Imaging
Funding Track Record
Investor Signal
“Company lists investors/supporters including Ouest Angels, WISEED, Dr. Fitoussi, and regional/institutional supporters such as Bpifrance, BNP Paribas, Région Pays de la Loire and local CCI; strategic partners noted include Fujifilm and Airbus engagement”